Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Md. Tanvir Kabir, Jannatul Ferdous Mitu, Raushanara Akter, Muhammad Furqan Akhtar, Ammara Saleem, Ahmed Al-Harrasi, Saurabh Bhatia, Md. Sohanur Rahman, Fouad Damiri, Mohammed Berrada & Md. Habibur Rahman. (2022) Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environmental Science and Pollution Research 29:31, pages 46385-46404.
Crossref
Crossref
Vanessa Boritzki, Harald Hübner, Anni Allikalt, Peter Gmeiner & Birgitta M. Wöhrl. (2021) Optimizing the Expression of Human Dopamine Receptors in Escherichia coli. International Journal of Molecular Sciences 22:16, pages 8647.
Crossref
Crossref
Falaq Naz & Yasir Hasan Siddique. (2020) Role of Genes and Treatments for Parkinson’s Disease. The Open Biology Journal 8:1, pages 47-65.
Crossref
Crossref
Patricia Di Ciano & Bernard Le Foll. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Anitha Kopinathan, Peter J Scammells, J Robert Lane & Ben Capuano. (2016)
Multivalent approaches and beyond: novel tools for the investigation of dopamine D
2
receptor pharmacology
. Future Medicinal Chemistry 8:11, pages 1349-1372.
Crossref
Crossref
Wei Xu, Yujun Wang, Zhongze Ma, Yi-Ting Chiu, Peng Huang, Khampaseuth Rasakham, Ellen Unterwald, David Y.-W. Lee & Lee-Yuan Liu-Chen. (2013) l-Isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors. Drug and Alcohol Dependence 133:2, pages 693-703.
Crossref
Crossref
Reet Reinart-Okugbeni, Argo Vonk, Ain Uustare, Zsuzsanna Gyulai, Attila Sipos & Ago Rinken. (2013) 1-substituted apomorphines as potent dopamine agonists. Bioorganic & Medicinal Chemistry 21:14, pages 4143-4150.
Crossref
Crossref
Deborah L Reichart, Richard T Hinkle, Frank R Lefever, Elizabeth T Dolan, Jeffrey A Dietrich, David R Sibley & Robert J Isfort. (2011) Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions. BMC Musculoskeletal Disorders 12:1.
Crossref
Crossref
Mette Skinbjerg, Yoon Namkung, Christer Halldin, Robert B. Innis & David R. Sibley. (2009)
Pharmacological characterization of 2-methoxy-
N
-propylnorapomorphine's interactions with D
2
and D
3
dopamine receptors
. Synapse 63:6, pages 462-475.
Crossref
Crossref
Yusuke Takeuchi & Kohji Fukunaga. (2003) Different effects of five dopamine receptor subtypes on nuclear factor-κB activity in NG108-15 cells and mouse brain. Journal of Neurochemistry 88:1, pages 41-50.
Crossref
Crossref
Guoping Cai, Hoau-Yan Wang & Eitan Friedman. (2002) Increased Dopamine Receptor Signaling and Dopamine Receptor-G Protein Coupling in Denervated Striatum. Journal of Pharmacology and Experimental Therapeutics 302:3, pages 1105-1112.
Crossref
Crossref
María de Jesús Gómez, Guy Rousseau, Réginald Nadeau, Roberto Berra, Gonzalo Flores & Jorge Suárez. (2002)
Functional and autoradiographic characterization of dopamine D
2
-like receptors in the guinea pig heart
. Canadian Journal of Physiology and Pharmacology 80:6, pages 578-587.
Crossref
Crossref
Caroline Sodja, Hung Fang, Tina Dasgupta, Maria Ribecco, P.Roy Walker & Marianna Sikorska. (2002) Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Molecular Brain Research 99:2, pages 83-91.
Crossref
Crossref
P. Sokoloff & J.-C. Schwartz. 2002. Dopamine in the CNS I. Dopamine in the CNS I
185
221
.
Jeffrey N. Joyce. (2001) Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacology & Therapeutics 90:2-3, pages 231-259.
Crossref
Crossref
Pietro Gareri, Umberto Falconi, Pasquale De Fazio & Giovambattista De Sarro. (2000) Conventional and new antidepressant drugs in the elderly. Progress in Neurobiology 61:4, pages 353-396.
Crossref
Crossref
Phillip G Zaworski, Glen L Alberts, Jeffrey F Pregenzer, Wha Bin Im, Jerry L Slightom & Gurnam S Gill. (2009)
Efficient functional coupling of the human D3 dopamine receptor to G
o
subtype of G proteins in SH‐SY5Y cells
. British Journal of Pharmacology 128:6, pages 1181-1188.
Crossref
Crossref
M C Coldwell, I Boyfield, A M Brown, G Stemp & D N Middlemiss. (2009)
Pharmacological characterization of extracellular acidification rate responses in human D
2(long)
, D
3
and D
4.4
receptors expressed in Chinese hamster ovary cells
. British Journal of Pharmacology 127:5, pages 1135-1144.
Crossref
Crossref
Kevin W. Moore, Katrine Bonner, Elizabeth A. Jones, Frances Emms, Paul D. Leeson, Rosemary Marwood, Shil Patel, Smita Patel, Michael Rowley, Steven Thomas & Robert W Carling. (1999) 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D4 receptors. Bioorganic & Medicinal Chemistry Letters 9:9, pages 1285-1290.
Crossref
Crossref
Eldo V. Kuzhikandathil, Weifeng Yu & Gerry S. Oxford. (1998) Human Dopamine D3 and D2L Receptors Couple to Inward Rectifier Potassium Channels in Mammalian Cell Lines. Molecular and Cellular Neuroscience 12:6, pages 390-402.
Crossref
Crossref
CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON, MOHAMED JABER & MARC G. CARON. (1998) Dopamine Receptors: From Structure to Function. Physiological Reviews 78:1, pages 189-225.
Crossref
Crossref
M.B.A. Djamgoz, M.W. Hankins, J. Hirano & S.N. Archer. (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Research 37:24, pages 3509-3529.
Crossref
Crossref
Susan W. Robinson & Marc G. Caron. (1997)
Selective Inhibition of Adenylyl Cyclase Type V by the Dopamine D
3
Receptor
. Molecular Pharmacology 52:3, pages 508-514.
Crossref
Crossref
Linda J. Bristow, Mark S. Kramer, Jan Kulagowski, Smita Patel, C.Ian Ragan & Guy R. Seabrook. (1997) Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist. Trends in Pharmacological Sciences 18:4, pages 186-188.
Crossref
Crossref
L.J. Bristow, M.S. Kramer, J. Kulagowski, S. Patel, C.I. Ragan & G.R. Seabrook. (1997) Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist. Trends in Pharmacological Sciences 18:6, pages 186-188.
Crossref
Crossref
Vinod R. Hegde, Ping Dai, Christine Ladislaw, Mahesh G. Patel, Mohindar S. Puar & Jonathan A. Pachter. (1997) D4 dopamine receptor-selective compounds from the Chinese plant Phoebe chekiangensis. Bioorganic & Medicinal Chemistry Letters 7:9, pages 1207-1212.
Crossref
Crossref
J.-F. Li?geois & J. Bruhwyler. 1997. Proceedings XIVth International Symposium on Medicinal Chemistry. Proceedings XIVth International Symposium on Medicinal Chemistry
271
290
.
Susan W. Robinson & Marc G. Caron. 1997. The Dopamine Receptors. The Dopamine Receptors
137
165
.
B.J. Bowery, Z. Razzaque, F. Emms, S. Patel, S. Freedman, L. Bristow, J. Kulagowski & G.R. Seabrook. (2012)
Antagonism of the effects of (+)‐PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D
2
receptor antagonist L‐741,626
. British Journal of Pharmacology 119:7, pages 1491-1497.
Crossref
Crossref
Daniel Lévesque. (1996) Aminotetralin drugs and D3 receptor functions. Biochemical Pharmacology 52:4, pages 511-518.
Crossref
Crossref
B. J. Kinon & J. A. Lieberman. (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124:1-2, pages 2-34.
Crossref
Crossref
Mohamed Jaber, Susan W Robinson, Cristina Missale & Marc G Caron. (1996) Dopamine receptors and brain function. Neuropharmacology 35:11, pages 1503-1519.
Crossref
Crossref